Paragon Capital Management (Utah)’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,029
Closed -$1.34M 80
2024
Q3
$1.34M Buy
4,029
+24
+0.6% +$9.12K 0.99% 43
2024
Q2
$1.65M Sell
4,005
-112
-3% -$44.4K 1.26% 28
2024
Q1
$1.66M Sell
4,117
-1,258
-23% -$442K 1.25% 34
2023
Q4
$1.65M Buy
5,375
+2
+0% +$540 1.32% 23
2023
Q3
$1.3M Buy
+5,373
New +$1.37M 1.11% 34

Other funds holding MEDP

Paragon Capital Management (Utah)'s MEDP Position: Q4 2024 in Review

Paragon Capital Management (Utah) sold out of Medpace (MEDP) in Q4 2024, closing a stake of 4,029 shares — an estimated $1.34M sold.

Paragon Capital Management (Utah) first reported a position in MEDP in Q3 2023 and held it in 5 quarters. The position peaked at $1.66M in Q1 2024. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Paragon Capital Management (Utah) reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Paragon Capital Management (Utah) sold 4,029 Medpace shares in Q4 2024, an estimated $1.34M.
  • Paragon Capital Management (Utah) first reported a position in Medpace in Q3 2023 and held it in 5 quarters.
  • Paragon Capital Management (Utah)'s Medpace position peaked at $1.66M in Q1 2024.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Paragon Capital Management (Utah)'s 13F filing for Q4 2024, filed 27 Jan 2025.